Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CTSK | P43235 | 2/20 | 0.46 |
| ▸ | ACE | P12821 | 1/20 | 0.45 |
| ▸ | REN | P00797 | 2/20 | 0.45 |
| ▸ | CTSS | P25774 | 2/20 | 0.44 |
| ▸ | CTSL | P07711 | 1/20 | 0.44 |
| ▸ | CTSB | P07858 | 1/20 | 0.44 |
| ▸ | PTPN1 | P18031 | 2/20 | 0.43 |
| ▸ | PTPRA | P18433 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6830642 | 0.91 | CTSK (0.47) | CTSKACERENCTSSCTSL | |
| SCHEMBL6796549 | 0.87 | PPARG (0.45) | CTSKCTSSCTSLCTSBPTPN1 | |
| SCHEMBL6916264 | 0.83 | REN (0.45) | CTSKACERENCTSSCTSL | |
| SCHEMBL9438871 | 0.81 | CTSK (0.57) | CTSKACECTSSCTSLCTSB | |
| SCHEMBL6796546 | 0.79 | REN (0.45) | CTSKACERENCTSSCTSL | |
| SCHEMBL7064449 | 0.78 | CTSK (0.43) | CTSK | |
| SCHEMBL7572392 | 0.78 | PTPN1 (0.70) | PTPN1PTPRA | |
| SCHEMBL6916272 | 0.77 | PTPN1 (0.68) | CTSKCTSSCTSLCTSBPTPN1 | |
| SCHEMBL9439254 | 0.76 | BCL2 (0.56) | CTSKRENPTPN1 | |
| SCHEMBL7618822 | 0.76 | REN (0.67) | CTSKACERENCTSSCTSL |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20040167183-A1 | Phenethylamino sulfamic acids | THE PROCTER & GAMBLE COMPANY | 2004-08-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040167183-A1 | Phenethylamino sulfamic acids | PTPRM, PTPRS, PTPRE | CTSK 2457/4885ACE 858/4885REN 343/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.